| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Regular Articles |
Department of Medical Oncology, Dana Farber Cancer Institute [R. C. O., C. W. B., K. K., M. D., C. C., N. E. S., L. C.], Department of Biostatistics, Harvard School of Public Health [A. S., X. Z., W. H. W.], Belfer Cancer Genomics Centre, Dana Farber Cancer Institute [M. D., C. C.], and Department of Dermatology, Harvard Medical School [L. C.], Boston, Massachusetts 02115; Department of Automation, Tsinghua University, Beijing 100084, China [X. Z.]; and Department of Statistics, Harvard University, Cambridge, Massachusetts 02138 [W. H. W.]
Chromosomal numerical aberrations (CNAs), particularly regional amplifications and deletions, are a hallmark of solid tumor genomes. These genomic alterations carry the potential to convey etiologic and clinical significance by virtue of their clonality within a tumor cell population, their distinctive patterns in relation to tumor staging, and their recurrence across different tumor types. In this study, we showed that array-based comparative genomic hybridization (CGH) analysis of genome-wide CNAs can classify tumors on the basis of differing etiologies and provide mechanistic insights to specific biological processes. In a RAS-induced p19Arf-/- mouse model that experienced accelerated melanoma formation after UV exposure, array-CGH analysis was effective in distinguishing phenotypically identical melanomas that differed solely by previous UV exposure. Moreover, classification by array-CGH identified key CNAs unique to each class, including amplification of cyclin-dependent kinase 6 in UV-treated cohort, a finding consistent with our recent report that UVB targets components of the p16INK4a-cyclin-dependent kinase-RB pathway in melanoma genesis (K. Kannan, et al., Proc. Natl. Acad. Sci. USA, 21: 2003). These results are the first to establish the utility of array-CGH as a means of etiology-based tumor classification in genetically defined cancer-prone models.
This article has been cited by other articles:
![]() |
F. Rapaport, E. Barillot, and J.-P. Vert Classification of arrayCGH data using fused SVM Bioinformatics, July 1, 2008; 24(13): i375 - i382. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Stark and N. Hayward Genome-Wide Loss of Heterozygosity and Copy Number Analysis in Melanoma Using High-Density Single-Nucleotide Polymorphism Arrays Cancer Res., March 15, 2007; 67(6): 2632 - 2642. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Chin, L. A. Garraway, and D. E. Fisher Malignant melanoma: genetics and therapeutics in the genomic era. Genes & Dev., August 15, 2006; 20(16): 2149 - 2182. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Guillaud-Bataille, A. Valent, P. Soularue, C. Perot, M.-d.-M. Inda, A. Receveur, S. Smaili, H. R. Crollius, J. Benard, A. Bernheim, et al. Detecting single DNA copy number variations in complex genomes using one nanogram of starting DNA and BAC-array CGH Nucleic Acids Res., July 29, 2004; 32(13): e112 - e112. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. L. Paris, A. Andaya, J. Fridlyand, A. N. Jain, V. Weinberg, D. Kowbel, J. H. Brebner, J. Simko, J.E. V. Watson, S. Volik, et al. Whole genome scanning identifies genotypes associated with recurrence and metastasis in prostate tumors Hum. Mol. Genet., July 1, 2004; 13(13): 1303 - 1313. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |